Barbara Binzak Blumenfeld, shareholder in the firm's FDA & Biotechnology section, comments on where the Samsung Galaxy Watch may fall within the regulation of medical devices in The Verge's article "Samsung's Galaxy Watch is Supposed to Measure Blood Pressure - But How Accurate Will it Be?"